LAUSR

Obesity is associated with increased CV risk. Using data from National Health and Nutrition Examination Surveys (NHANES; 2003-2012), we estimated frequency and prevalence of obesity in U.S. adults (≥20 years). Participants in 5 NHANES surveys with fasting blood serum data (n=11,256) were pooled and categorized as overweight, obese, or morbidly obese (BMI 25-29.9, 30-39.9, or ≥40 kg/m2, respectively). Results are stratified by age, sex, and ethnicity. Extrapolations to the U.S. adult population were performed using the direct method to the 2011-2012 U.S. Census. Proportion of U.S. adults categorized as ≥overweight is high, irrespective of age, sex, or ethnicity (Table). Obesity prevalence is high in adults aged 20-39 years (30% of men and 33% of women) and those aged ≥60 years (35% of men and 38% of women). In men, obesity/morbid obesity prevalence is similar between ethnic groups. However, non-Hispanic black women have a higher prevalence of obesity/morbid obesity than Hispanic and non-Hispanic white women. Prevalence of ≥overweight is highest in Hispanic men and women aged ≥60 years, and non-Hispanic black women. In the U.S. adult population, obesity levels remain high, irrespective of age, sex, and ethnicity. Overall, 73% of men and 65% of women were categorized as overweight, obese, or morbidly obese. There is a need for effective preventive interventions to reduce the burden of obesity. Disclosure P.P. Toth: Speaker9s Bureau; Self; Amarin Corporation. Consultant; Self; Amarin Corporation. Speaker9s Bureau; Self; Amgen Inc.. Consultant; Self; Amgen Inc.. Speaker9s Bureau; Self; Kowa Pharmaceuticals America, Inc.. Consultant; Self; Kowa Pharmaceuticals America, Inc.. Speaker9s Bureau; Self; Merck Sharp & Dohme Corp.. Consultant; Self; Merck Sharp & Dohme Corp.. Speaker9s Bureau; Self; Regeneron Pharmaceuticals, Inc.. Consultant; Self; Regeneron Pharmaceuticals, Inc.. Speaker9s Bureau; Self; Sanofi US, Novo Nordisk Inc. M. Palmer: Other Relationship; Self; Boehringer Ingelheim GmbH.